Experimental and Human Evidence for Lipocalin‐2 (Neutrophil Gelatinase‐Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and Heart Failure

BACKGROUND: Cardiac hypertrophy increases the risk of developing heart failure and cardiovascular death. The neutrophil inflammatory protein, lipocalin‐2 (LCN2/NGAL), is elevated in certain forms of cardiac hypertrophy and acute heart failure. However, a specific role for LCN2 in predisposition and...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Francine Z., Prestes, Priscilla R., Byars, Sean G., Ritchie, Scott C., Würtz, Peter, Patel, Sheila K., Booth, Scott A., Rana, Indrajeetsinh, Minoda, Yosuke, Berzins, Stuart P., Curl, Claire L., Bell, James R., Wai, Bryan, Srivastava, Piyush M., Kangas, Antti J., Soininen, Pasi, Ruohonen, Saku, Kähönen, Mika, Lehtimäki, Terho, Raitoharju, Emma, Havulinna, Aki, Perola, Markus, Raitakari, Olli, Salomaa, Veikko, Ala‐Korpela, Mika, Kettunen, Johannes, McGlynn, Maree, Kelly, Jason, Wlodek, Mary E., Lewandowski, Paul A., Delbridge, Lea M., Burrell, Louise M., Inouye, Michael, Harrap, Stephen B., Charchar, Fadi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669193/
https://www.ncbi.nlm.nih.gov/pubmed/28615213
http://dx.doi.org/10.1161/JAHA.117.005971

Ejemplares similares

Ejemplares similares